Fred Alger Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-386
Closed -$305K 469
2020
Q2
$305K Buy
+386
New +$291K ﹤0.01% 415
2020
Q1
Sell
-1,676
Closed -$1.91M 553
2019
Q4
$1.91M Buy
+1,676
New +$1.82M 0.01% 293
2019
Q3
Sell
-2,124
Closed -$3.5M 487
2019
Q2
$3.5M Sell
2,124
-1,613
-43% -$2.79M 0.01% 254
2019
Q1
$7.62M Buy
3,737
+1,266
+51% +$2.23M 0.03% 195
2018
Q4
$3.17M Sell
2,471
-1,627
-40% -$2.5M 0.01% 254
2018
Q3
$7.75M Sell
4,098
-250
-6% -$516K 0.03% 187
2018
Q2
$8.84M Sell
4,348
-1,003
-19% -$2.29M 0.04% 186
2018
Q1
$11.8M Buy
5,351
+613
+13% +$1.56M 0.06% 174
2017
Q4
$10.9M Sell
4,738
-566
-11% -$1.15M 0.05% 174
2017
Q3
$9.44M Sell
5,304
-283
-5% -$395K 0.04% 183
2017
Q2
$7.6M Buy
5,587
+160
+3% +$193K 0.04% 193
2017
Q1
$6.39M Buy
5,427
+1,896
+54% +$1.93M 0.03% 204
2016
Q4
$2.82M Buy
3,531
+215
+6% +$171K 0.02% 240
2016
Q3
$2.91M Buy
3,316
+1,171
+55% +$848K 0.01% 236
2016
Q2
$1.2M Sell
2,145
-486
-18% -$275K 0.01% 314
2016
Q1
$1.45M Sell
2,631
-1,127
-30% -$692K 0.01% 345
2015
Q4
$3.13M Sell
3,758
-3,346
-47% -$3.34M 0.02% 302
2015
Q3
$7.87M Sell
7,104
-5,128
-42% -$9.35M 0.04% 222
2015
Q2
$26.7M Buy
12,232
+2,529
+26% +$5.15M 0.12% 130
2015
Q1
$15.2M Sell
9,703
-4,495
-32% -$5.93M 0.07% 212
2014
Q4
$16.9M Buy
14,198
+2,296
+19% +$1.53M 0.08% 196
2014
Q3
$5.53M Sell
11,902
-1,436
-11% -$663K 0.03% 331
2014
Q2
$6.66M Sell
13,338
-7,765
-37% -$2.49M 0.03% 333
2014
Q1
$6.22M Buy
21,103
+2,771
+15% +$840K 0.03% 335
2013
Q4
$4.98M Buy
+18,332
New +$5.12M 0.03% 337

Other funds holding BLUE

Fred Alger Management's BLUE Position: Q3 2020 in Review

Fred Alger Management sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 386 shares — an estimated $305K sold.

Fred Alger Management first reported a position in BLUE in Q4 2013 and held it in 25 quarters. The position peaked at $26.7M in Q2 2015. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • Fred Alger Management reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • Fred Alger Management sold 386 bluebird bio shares in Q3 2020, an estimated $305K.
  • Fred Alger Management first reported a position in bluebird bio in Q4 2013 and held it in 25 quarters.
  • Fred Alger Management's bluebird bio position peaked at $26.7M in Q2 2015.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on Fred Alger Management's 13F filing for Q3 2020, filed 13 Nov 2020.